Amwill Health Care Ltd

AGM Details

• AGM held on 14 August 2026 at 01:00 IST via VC/OAVM.
• Deemed venue: Registered Office, Bangalore.
• Quorum: 20 members present.
• Remote e-Voting window: Aug 11–13, 2026; e-Voting during AGM.
• Scrutinizer appointed for e-voting; meeting concluded at 01:42 PM.

Resolutions

• Ordinary: Adopt Audited Financial Statements for year ended 31 March 2026.
• Ordinary: Declare Final Dividend on Equity Shares for FY ended 31 March 2026.
• Ordinary: Re-appoint Sapna Parmar (DIN 10198855) on rotation.
• Special: Re-appoint Tarun Gandhi as Managing Director.
• Special: Re-appoint Anand Gandhi as Managing Director.

Voting & Results

• Voting results will be disseminated separately to BSE and NSDL.
• No outcome details disclosed in this filing.

Dividend Details

• Final dividend amount per share not disclosed.

Directors & MD Appointments

• Sapna Parmar re-appointment on rotation.
• Tarun Gandhi re-appointed as MD.
• Anand Gandhi re-appointed as MD.

Auditors

• No change to statutory auditor; attendance noted.

Hybrid treasury investment framework

• Investment Committee approved a hybrid treasury framework using internal accruals on Aug 8, 2026.
• Debt-related investments (G-Secs, T-bills, government bonds, NCDs, CPs, other debt securities) cap ₹10 crore.
• Listed equity and IPO subscriptions cap ₹2 crore.
• Private credit funds, AIFs, structured debt cap ₹15 crore.
• Invoice discounting platforms and similar investments cap ₹3 crore.
• SIPs in mutual funds cap ₹3 crore (aggregate).
• Investment does not involve related party transactions.
• Compliance: SEBI Listing Regulations disclosures; available on company's website.

Tarun Gandhi – MD Re-appointment

• Re-appointed as MD & KMP for five years from Jan 27, 2027 to Jan 26, 2032.
• Subject to shareholders' approval via special resolution at the 9th AGM.
• Relation: Relative of Anand Gandhi.
• Brief profile: Commerce degree; 10+ years in financial management and business development.

Anand Gandhi – MD Re-appointment

• Re-appointed as MD & KMP for five years from Jan 27, 2027 to Jan 26, 2032.
• Subject to shareholders' approval via special resolution at the 9th AGM.
• Relation: Relative of Tarun Gandhi.
• Brief profile: Pharmacy degrees; 10+ years in brand placement, marketing, and dermatology.

Scrutinizer appointment

• Saurabh Talwar, CS, appointed Scrutinizer for remote and e-voting at AGM.
• Purpose: scrutinize remote e-Voting and e-Voting during eAGM.
• Designation: Company Secretary (COP No. 13338).

Appointments/Resignations

• Tarun Gandhi re-appointed MD & KMP for 5 years, Jan 27, 2027–Jan 26, 2032, subject to AGM approval.
• Anand Gandhi re-appointed MD & KMP for 5 years, Jan 27, 2027–Jan 26, 2032, subject to AGM approval.
• Directors Tarun Gandhi and Anand Gandhi are relatives.
• Both not debarred from holding director roles by SEBI or NSE authorities.

AGM Details

• 9th AGM scheduled for Aug 14, 2026 via VC/OAVM.
• Record date fixed as Aug 8, 2026 for AGM attendance and voting.
• Remote e-voting window Aug 11–13, 2026 via NSDL.
• Scrutinizer Mr. Saurabh Talwar appointed for AGM e-voting.
• Notice of AGM and Annual Report to be circulated electronically; available on company/BSE websites.

Financial Reporting & Communications

• FY2025-26 annual report including audited FS, Board's Report, MD&A, CSR to be laid before AGM.

Dematerialisation/rematerialisation status

• No dematerialisation/rematerialisation requests were received during the quarter ended 30 June 2026.
• RTA confirms compliance with Regulation 74(5) for the quarter ended 30 June 2026.